escalation safety and tolerability pilot study. Diabetes Care. 2015 Sep; 38(9):
1742-9. doi: 10.2337/dc14-2830.
Wu H, Mahato RI. Mesenchymal stem cell-based therapy for type 1
diabetes. Discov Med. 2014 Mar; 17(93): 139-43
Chương 16
Sun, L, Akiyama K, Zhang H, et al. Mesenchymal stem cell transplantation
reverses multi-organ dysfunction in systemic lupus erythematosus mice and
humans. Stem Cells. 2009; 27(6): 1421-1432. doi: 10.1002/stem.68.
Liang J, Zhang H, Wang H, et al. Allogenic mesenchymal stem cells
transplantation in refractory systemic lupus erythematosus: a pilot clinical study.
Ann Rheum Dis. 2010; 69(8): 1423-9. doi: 10.1136/ard.2009.123463.
Sun L, Wang D, Liang J, et al. Umbilical cord mesenchymal stem cell
transplantation in severe and refractory systemic lupus erythematosus. Arthritis
Rheum. 2010; 62(8): 2467-75. doi: 10.1002/art.27548.
Shi D, Wang D, Li X, et al. Allogeneic transplantation of umbilical cord-
derived mesenchymal stem cells for diffuse alveolar hemorrhage in systemic
lupus erythematosus. Clin Rheumatol. 2012; 31(5): 841-6. doi: 10.1007/s10067-
012-1943-2.
Wang D, Zhang H, Liang J, et al. Allogeneic mesenchymal stem cell
transplantation in severe and refractory systemic lupus erythematosus: 4 years of
experience.
Cell
Transplant.
2013;
22(12):
2267-77.
doi:
10.3727/096368911X582769.
Medical University of South Carolina. MsciSLE: MSCs in SLE trial. In:
ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US).
2000-
[cited
2016
July].
Available
from:
https://clinicaltrials.gov/ct2/show/NCT02633163
NLM
Identifier:
NCT02633163.
Chương 17
Baglio SR, Pegtel DM, Baldini N. Mesenchymal stem cell secreted vesicles
provide novel opportunities in (stem) cell-free therapy. Front Physiol. 2012; 3:
